Advertisement
Advertisement

PBM

PBM logo

Psyence Biomedical Ltd. Common Shares

5.59
USD
Sponsored
-0.43
-7.14%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

5.50

-0.09
-1.59%

Psyence Biomedical Ltd. Common Shares Profile

About

Psyence Biomed is a life science biotechnology company which focus on natural psychedelics. The company's operating divisions include Psyence Production, Psyence Therapeutics and Psyence Function which operates in Canada, the United Kingdom, Southern Africa, Australia and a presence in the United States. Psyence Biomed, formerly known as Newcourt Acquisition Corp, is based in NEW YORK.

Info & Links

CEO

Neil Maresky

Headquarters

121 Richmond Street West, Penthouse Suite1300
Toronto, A6 M5H 2K1, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.psyencebiomed.com

Auditor

MNP LLP

Share holders

--

Employees

12

Psyence Biomedical Ltd. Common Shares Statistics

Valuation Measures

Market Capitalization2

12.62M

Enterprise Value

5.42M

Enterprise Value/EBITDA(ttm)

-3.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.06

Price to Cash(ytd)

0.22

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-6.35%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-1.51M

Net Income Available to Common(ttm)

-753.30K

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.31

52-Week Change

-76.92%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

985.00K

% Held by Insiders

3.60%

% Held by Institutions

77.44%

Balance Sheet

Total Cash(mrq)

7.20M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.09%

Quick Ratio(mrq)

8.09%

Book Value Per Share(mrq)

39.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.56

Free Cash Flow(ytd)

-2.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement